CHM-1, a New Vascular Targeting Agent, Induces Apoptosis of Human Umbilical Vein Endothelial Cells via p53-mediated Death Receptor 5 Up-regulation

Antivascular Actions of Microtubule-Binding Drugs

(2009) E. L. Schwartz   CLINICAL CANCER RESEARCH

Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line

(2009) Shu-Chun Hsu et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Endogenous inhibitors of angiogenesis

(2009) Domenico Ribatti   LEUKEMIA RESEARCH

Anticancer strategies involving the vasculature

(2009) Victoria L. Heath et al.   Nature Reviews Clinical Oncology

Molecular mechanism of the inhibitory effect of KS-5 on bFGF-induced angiogenesis in vitro and in vivo

(2008) Chieh-Yu Peng et al.   CANCER LETTERS

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

(2008) Devalingam Mahalingam et al.   CANCER TREATMENT REVIEWS

Moscatilin Induces Apoptosis in Human Colorectal Cancer Cells: A Crucial Role of c-Jun NH2-Terminal Protein Kinase Activation Caused by Tubulin Depolymerization and DNA Damage

(2008) T.-H. Chen et al.   CLINICAL CANCER RESEARCH

15-Deoxy-Δ(12,14)-prostaglandin J2Induces Vascular Endothelial Cell Apoptosis through the Sequential Activation of MAPKS and p53

(2008) Tsung-Chuan Ho et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo

(2008) S.-W. Wang et al.   MOLECULAR CANCER THERAPEUTICS

Caspases in apoptosis and beyond

(2008) J Li et al.   ONCOGENE

Apoptosis: controlled demolition at the cellular level

(2007) Rebecca C. Taylor et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY